AzTrials
AzTrials

Postural Kyphosis, Cervicothoracic RegionNCT05458206

Effect of Mulligan Snag and Diaphragmatic Release on Thoracic Kyphosis

A study testing mulligan snag mobilization and diaphragmatic release in people with Postural Kyphosis, Cervicothoracic Region, run by Cairo University at 2 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the aim of this study is to investigate the efficacy of mulligan snag mobilisation and diaphragmatic release on upper crossed syndrome Read more about this study

Who is it for?
Ages 17 to 22 years
What is being tested?
mulligan snag mobilization and diaphragmatic release
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesEgypt
Study dates
20 Oct 2022to 20 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 22 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Age ranged from 17 to 22 years .
  • Body Mass Index from 20 to 25 kg/m² .
  • All participants have an intensity of neck pain on VAS (4-8) (moderate cases) .
  • The subjects were chosen from both sexes.
  • All participants have kyphosis angle ≥42°
  • All participants have mechanical neck pain and FHP (craniovertebral angle CVA < 49) CVA of < 49) .

Who cannot join

  • Malignancy
  • Fractures of the cervical spine
  • Cervical radiculopathy or myelopathy
  • Vascular syndromes such as vertebrobasilar insufficiency
  • Rheumatoid arthritis
  • Neck or upper back surgery
Show all 9Show fewer
  • Taking anticoagulants
  • Local infection
  • Whiplash injury

Trial locations and contacts

2 sites in 1 country.

Egypt2 sites
  • Faculty of physical therapy Cairo university

    Cairo, Giza Governorate, 12613

  • Faculty of physical therapy

    Cairo, Giza Governorate, 12613

Other trials in Egypt

About this study

the aim of this study is to investigate the efficacy of mulligan snag mobilisation and diaphragmatic release on upper crossed syndrome

Read the detailed description

Acquired postural disorders can be a consequence, to a large extent, of contemporary living and working conditions. Some of the most typical factors include continuous use of mobile phones and computers, working in sedentary jobs. Prolonged incorrect posture and reduced physical activity present a dis-balance in the musculature . It can also lead to vision issues, as well as headaches, musculoskeletal issues, and pain, as well as a multitude of other symptoms.

Upon the available research studies, there is not study conducted to investigate the effect of mulligan SNAG mobilization and diaphragmatic release in upper crossed syndrome patients this trial has four groups; one will receive diaphragmatic release + conventional, the second will receive mulligan SNAG mobilization, and conventional, the third will receive mulligan SNAG mobilization+diaphragmatic release+conventional, the fourth subjects will receive conventional

Being tested
mulligan snag mobilization and diaphragmatic release

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mulligan snag mobilization and diaphragmatic releaseOther

    The patients will be in the supine position. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ). During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally. During exhalation, the therapist will deepen hand contact toward the inner coastal margins.

    mulligan snag, Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this "glide" as the patient actively moves in any range of physiological movement

Study groups in NCT05458206
Study groupRoleWhat they receive
diaphragmatic release, and conventionalExperimentalDiaphragmatic release: The patients will be positioned in the supine position. The therapist stood at the head of the patient. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ) with hypothenar regions of the hands and the last three fingers. During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally, while elevating the ribs simultaneously. During exhalation, the therapist will deepen hand contact toward the inner coastal margins for 5 to 7 minute conventional therapy: the patient will receive chin-in, interscapular exercises, and pectoralis stretch
Receives: Other: mulligan snag mobilization and diaphragmatic release
mulligan SNAG mobilization, and conventionalExperimentalmulligan snag: Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this "glide" as the patient actively moves in any range of physiological movement and then sustains it at the end range position for a few seconds. (3 sets,10 repetitions) conventional therapy: the patient will receive chin-in, interscapular exercises, and pectoralis stretch
Receives: Other: mulligan snag mobilization and diaphragmatic release
mulligan SNAG mobilization, diaphragmatic release, and conventionalExperimentalDiaphragmatic release: The patients will be positioned in the supine position. The therapist stood at the head of the patient. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ) with hypothenar regions of the hands and the last three fingers. During the patient's inspiration, the therapist will gently pull the points of hand contacts toward the head and slightly laterally, while elevating the ribs simultaneously. During exhalation, the therapist will deepen hand contact toward the inner coastal margins. (5 to 7 minutes) mulligan snag: Apply a passive intervertebral movement in a superior anterior direction along the facet plane. While maintaining this "glide" as the patient actively moves in any range of physiological movement and then sustains it at the end range position for a few seconds(3 sets,10 repetitions) conventional therapy: the patient will receive chin-in, interscapular exercises, and pectoralis stretch
Receives: Other: mulligan snag mobilization and diaphragmatic release
the conventional therapyActive comparatorthe patient will receive chin-in, inter-scapular exercises, and pectoralis stretch (3 sets,10 repetitions)
Receives: Other: mulligan snag mobilization and diaphragmatic release

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain intensity

    The scale that will be used is the Visual analogue scale;each subject will be instructed to put point on a line from no pain to tolerable pain

    Measured: up to four weeks

Secondary outcomes (1)
  1. cervical range of motion

    theCROM device will placed on patient's head while he/she seated and looking forward the difference between the ponter value and the value after movement will be recorded as the motion angle of the cervical vertebrae

    Measured: up to four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2022
  2. Study start20 Oct 2022
  3. Primary completion20 Mar 2023
  4. Study completion20 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
EFFECT OF MULLIGAN SNAG MOBILISATION AND DIAPHRAGMATIC RELEASE
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05458206
Sponsor's protocol ID
p.t.REC/012/003548
Status last verified
Nov 2022
First submitted
11 Jul 2022
Last updated
25 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing mulligan snag mobilization and diaphragmatic release in people with Postural Kyphosis, Cervicothoracic Region, run by Cairo University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain intensity (time frame: up to four weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in